Bonti is a rapidly emerging biotechnology company founded by world class neurotoxin experts with proven success at Allergan. The team is uniquely qualified to develop unprecedented treatment paradigms driven by a novel neurotoxin platform to become an innovative leader in both aesthetic and therapeutic markets.